Marks Group Wealth Management »

Biontech Se shares owned by Marks Group Wealth Management

Quarter-by-quarter ownership of Biontech Se (BNTX) shares owned by Marks Group Wealth Management from 13F filings

Historical chart of Marks Group Wealth Management investment in Biontech Se

Tip: Access up to 7 years of quarterly data

All positions including Biontech Se held by Marks Group Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biontech Se by Marks Group Wealth Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $337k 3.7k 92.25
2023-12-31 $405k 3.8k 105.54

More positions owned by Marks Group Wealth Management

Alphabet Cap Stk Cl C (GOOG)
Stryker Corporation (SYK)
Apple (AAPL)
Visa Com Cl A (V)
Republic Services (RSG)
Intercontinental Exchange (ICE)
UnitedHealth (UNH)
Emcor (EME)
Microsoft Corporation (MSFT)
FactSet Research Systems (FDS)
Meta Platforms Cl A (META)
Moody's Corporation (MCO)
salesforce (CRM)
Copart (CPRT)
Msci (MSCI)

View all positions for Marks Group Wealth Management

Top funds holding Biontech Se

Baillie Gifford & Co
PRIMECAP Management Company
Harding Loevner
Flossbach Von Storch
Ubs Global Asset Management Americas
Altrinsic Global Advisors
Voloridge Investment Management
Deutsche Bank Aktiengesellschaft
ClearBridge Advisors
DekaBank Deutsche Girozentrale
Citadel Advisors
Gilder, Gagnon, Howe & Co
Squarepoint Ops
UBS Group
Millennium Management

View all funds holding Biontech Se